Cramer Pamela J. bought RYTM

July 9, 2025 · Form 4 insider transaction

Cramer Pamela J. bought 5,025 shares of Rhythm Pharmaceuticals, Inc. at $27.35 per share, a transaction worth $137.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.